2018
DOI: 10.1080/19420862.2018.1553476 View full text |Buy / Rent full text
|
|

Abstract: Increasing attention has been paid to developability assessment with the understanding that thorough evaluation of monoclonal antibody lead candidates at an early stage can avoid delays during late-stage development. The concept of developability is based on the knowledge gained from the successful development of approximately 80 marketed antibody and Fc-fusion protein drug products and from the lessons learned from many failed development programs over the last three decades. Here, we reviewed antibody qualit… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
117
0
1

Publication Types

Select...

Relationship

0
0

Authors

Journals